Price Target
Search documents
Wall Street Analysts Predict a 44.41% Upside in Encore Capital Group (ECPG): Here's What You Should Know
ZACKSยท 2025-05-12 15:01
Core Viewpoint - Encore Capital Group (ECPG) has shown a significant price increase of 38.2% over the past four weeks, with a mean price target of $58.50 indicating a potential upside of 44.4% from the current price of $40.51 [1] Price Targets and Analyst Consensus - The average price target for ECPG ranges from a low of $55 to a high of $66, with a standard deviation of $5.07, suggesting a relatively high agreement among analysts [2] - The lowest estimate indicates a potential increase of 35.8%, while the most optimistic estimate suggests a 62.9% upside [2] - Analysts' price targets should be approached with caution, as they may not always accurately reflect future stock movements [3][7] Earnings Estimates and Analyst Optimism - Analysts have shown strong agreement in revising ECPG's earnings estimates higher, which is a positive indicator for potential stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 11.8% over the past month, with three estimates revised upward and no negative revisions [12] - ECPG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Investment Potential - While the consensus price target may not be a reliable indicator of the extent of ECPG's potential gains, the direction implied by these targets appears to be a useful guide for further research [13]
Does Amneal (AMRX) Have the Potential to Rally 54.16% as Wall Street Analysts Expect?
ZACKSยท 2025-05-09 15:01
Shares of Amneal Pharmaceuticals (AMRX) have gained 7% over the past four weeks to close the last trading session at $7.46, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $11.50 indicates a potential upside of 54.2%.The mean estimate comprises four short-term price targets with a standard deviation of $0.58. While the lowest estimate of $11 indicates a 47.5% increase from the c ...
Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?
ZACKSยท 2025-05-08 15:02
Group 1 - Pfizer (PFE) closed at $22.79, with a 1.3% gain over the past four weeks, and a mean price target of $28.52 indicating a 25.1% upside potential [1] - The average of 21 short-term price targets ranges from $23 to $35, with a standard deviation of $3.16, suggesting variability in analyst estimates [2] - Analysts have shown increasing optimism about PFE's earnings prospects, with a 3.2% increase in the Zacks Consensus Estimate for the current year and no negative revisions [12][11] Group 2 - The Zacks Rank for PFE is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - A tight clustering of price targets, indicated by a low standard deviation, suggests a high degree of agreement among analysts regarding the stock's price movement [9] - While price targets can be misleading, the direction implied by them may serve as a useful guide for further research into the stock's potential [10][7]
Does Edison International (EIX) Have the Potential to Rally 27.5% as Wall Street Analysts Expect?
ZACKSยท 2025-05-05 15:01
Core Viewpoint - Edison International (EIX) shows potential for upside with a mean price target of $69.97, indicating a 27.5% increase from the current price of $54.88 [1] Price Targets and Analyst Consensus - The average price target consists of 16 estimates ranging from a low of $50.50 to a high of $86, with a standard deviation of $10.02, suggesting variability in analyst predictions [2] - The lowest estimate indicates an 8% decline, while the highest suggests a 56.7% upside, highlighting the range of opinions among analysts [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement direction, which can be a starting point for further research [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about EIX's earnings prospects, as evidenced by a trend of higher EPS estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 2% over the past month, with three estimates increasing and one decreasing [12] - EIX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13]
Wall Street Analysts Predict a 32.81% Upside in Triple Flag (TFPM): Here's What You Should Know
ZACKSยท 2025-05-05 15:01
Group 1 - The core viewpoint is that Triple Flag Precious Metals (TFPM) has significant upside potential, with a mean price target of $27.81 indicating a 32.8% increase from its current price of $20.94 [1] - Analysts have set 11 short-term price targets for TFPM, ranging from a low of $19 to a high of $36.50, with a standard deviation of $6.24, suggesting variability in estimates [2] - The consensus among analysts indicates that TFPM is expected to report better earnings than previously estimated, which historically correlates with stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for TFPM's current year earnings has increased by 12.3% over the past month, with five estimates revised upward and no negative revisions [12] - TFPM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While price targets are often viewed skeptically, the direction implied by these targets can serve as a useful guide for potential stock movements [10][11]
Does Lam Research (LRCX) Have the Potential to Rally 26.77% as Wall Street Analysts Expect?
ZACKSยท 2025-05-02 15:00
Shares of Lam Research (LRCX) have gained 10% over the past four weeks to close the last trading session at $71.73, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $90.93 indicates a potential upside of 26.8%.The mean estimate comprises 27 short-term price targets with a standard deviation of $12.03. While the lowest estimate of $70 indicates a 2.4% decline from the current pric ...
How Much Upside is Left in Synovus (SNV)? Wall Street Analysts Think 25.99%
ZACKSยท 2025-05-02 15:00
Synovus Financial (SNV) closed the last trading session at $44.10, gaining 10% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $55.56 indicates a 26% upside potential.The mean estimate comprises 16 short-term price targets with a standard deviation of $5.85. While the lowest estimate of $46 indicates a 4.3% increase from the current price level, the most optimistic analyst expects ...
Wall Street Analysts Believe First Business Financial Services (FBIZ) Could Rally 26.23%: Here's is How to Trade
ZACKSยท 2025-04-29 14:55
Core Viewpoint - First Business Financial Services (FBIZ) shows potential for significant upside, with a mean price target of $60.20 indicating a 26.2% increase from the current price of $47.69 [1] Price Targets - The average price target for FBIZ ranges from a low of $57 to a high of $62, with a standard deviation of $2.05, suggesting a relatively high agreement among analysts [2] - The lowest estimate indicates a 19.5% increase, while the highest suggests a 30% upside [2] Analyst Consensus and Earnings Estimates - Analysts are optimistic about FBIZ's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.9%, with one estimate moving higher and no negative revisions [12] Zacks Rank - FBIZ holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]
Does NCR Atleos (NATL) Have the Potential to Rally 59.76% as Wall Street Analysts Expect?
ZACKSยท 2025-04-02 15:00
Core Viewpoint - NCR Atleos (NATL) has shown a 5.3% increase in stock price over the past four weeks, with a mean price target of $43.20 indicating a potential upside of 59.8% from the current price of $27.04 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $14.38, where the lowest estimate is $29 (7.3% increase) and the highest is $60 (121.9% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about NATL's earnings prospects, as indicated by a strong agreement in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, one estimate has increased, leading to a 7.8% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - NATL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]
Wall Street Analysts Believe ChampionX (CHX) Could Rally 41.59%: Here's is How to Trade
ZACKSยท 2025-03-27 14:55
Core Viewpoint - ChampionX (CHX) shows potential for significant upside, with a mean price target of $43 indicating a 41.6% increase from the current price of $30.37 [1] Price Targets - The average price target from analysts ranges from a low of $39 to a high of $51, with a standard deviation of $4.86, suggesting a consensus among analysts [2] - The lowest estimate indicates a potential increase of 28.4%, while the highest suggests a 67.9% upside [2] Analyst Sentiment - Analysts are optimistic about CHX's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the last 30 days, one earnings estimate has increased, leading to a 2.1% rise in the Zacks Consensus Estimate [12] Zacks Rank - CHX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]